Overview

Efficacy of Oral Nigella Sativa as Adjuvant Therapy in Children With Moderate Persistent Asthma

Status:
NOT_YET_RECRUITING
Trial end date:
2026-10-31
Target enrollment:
Participant gender:
Summary
Complementary and adjunctive therapies are increasingly being explored to enhance asthma control and reduce airway inflammation. Nigella sativa (black seed) is a medicinal plant used traditionally in multiple regions and has demonstrated anti-inflammatory, immunomodulatory, and bronchodilator effects. Its potential as an adjuvant therapy in asthma has attracted attention in both preclinical and clinical research
Phase:
NA
Details
Lead Sponsor:
Tanta University
Treatments:
Fluticasone
Nigella sativa oil